☆ 4.7 Article

Interpretation of Relative Efficacy and Effectiveness for Influenza Vaccines

CLINICAL INFECTIOUS DISEASES (2022)

Related references

Note: Only part of the references are listed.

Article Immunology

Relative and Absolute Effectiveness of High-Dose and Standard-Dose Influenza Vaccine Against Influenza-Related Hospitalization Among Older Adults-United States, 2015-2017

Joshua D. Doyle et al.

Summary: The study found that during two US influenza seasons, the effectiveness of high-dose influenza vaccine for preventing influenza hospitalizations in adults aged >= 65 years was low to moderate, with high-dose vaccine offering greater effectiveness compared to standard-dose vaccine. None of these findings were statistically significant.

CLINICAL INFECTIOUS DISEASES (2021)

Add to Collection

Article Immunology

Influenza Vaccine Effectiveness in Inpatient and Outpatient Settings in the United States, 2015-2018

Mark W. Tenforde et al.

Summary: This study compared the effectiveness of influenza vaccination between inpatient and outpatient networks in the US, finding that inpatients were older and had more high-risk conditions than outpatients. The overall vaccine effectiveness across seasons was 31% for outpatients and 36% for inpatients, with some differences observed in strain-specific VE between the two groups.

CLINICAL INFECTIOUS DISEASES (2021)

Add to Collection

Article Immunology

Relative Effectiveness of the Cell-derived Inactivated Quadrivalent Influenza Vaccine Versus Egg-derived Inactivated Quadrivalent Influenza Vaccines in Preventing Influenza-related Medical Encounters During the 2018-2019 Influenza Season in the United States

Constantina Boikos et al.

Summary: This study estimated the relative vaccine effectiveness (rVE) of cell-propagated inactivated quadrivalent influenza vaccine (ccIIV4) versus egg-derived inactivated quadrivalent influenza vaccine (eIIV4) in preventing influenza-related medical encounters in the 2018-2019 US season. The results showed a statistically significantly greater reduction in influenza-related medical encounters in individuals vaccinated with ccIIV4 compared to eIIV4, supporting ccIIV4 as a potentially more effective public health measure against influenza.

CLINICAL INFECTIOUS DISEASES (2021)

Add to Collection

Article Medicine, General & Internal

Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease A Randomized Clinical Trial

Orly Vardeny et al.

Summary: In patients with high-risk cardiovascular disease, high-dose trivalent inactivated influenza vaccine did not significantly reduce all-cause mortality or cardiopulmonary hospitalizations compared with standard-dose quadrivalent inactivated influenza vaccine, but influenza vaccination remains strongly recommended in this population.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Add to Collection

Editorial Material Medicine, General & Internal

Influenza Vaccine for Patients With High-risk Cardiovascular Disease

Manish M. Patel et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Add to Collection

Article Immunology

Vaccine Effectiveness Against Influenza-Associated Hospitalizations Among Adults, 2018-2019, US Hospitalized Adult Influenza Vaccine Effectiveness Network

Jill M. Ferdinands et al.

Summary: The study estimated vaccine effectiveness for prevention of influenza-associated hospitalizations in adults during the 2018-2019 influenza season. The results showed positive effectiveness against influenza A(H1N1)pdm09 but no protection against influenza A(H3N2), with significant differences by age group noted.

JOURNAL OF INFECTIOUS DISEASES (2021)

Add to Collection

Article Immunology

Influenza Vaccine Effectiveness Against Hospitalization in the United States, 2019-2020

Mark W. Tenforde et al.

Summary: This study evaluated the effectiveness of the 2019-2020 influenza vaccine against influenza-associated hospitalization in the United States, showing a 41% reduction in risk of hospitalized influenza illness. Among the two major A(H1N1)pdmO9 subgroups, one subgroup had a vaccine effectiveness of 59%, while no effectiveness was observed in the other subgroup.

JOURNAL OF INFECTIOUS DISEASES (2021)

Add to Collection

Review Immunology

Variable seasonal influenza vaccine effectiveness across geographical regions, age groups and levels of vaccine antigenic similarity with circulating virus strains: A systematic review and meta-analysis of the evidence from test-negative design studies after the 2009/10 influenza pandemic

G. N. Okoli et al.

Summary: The study found consistent patterns in seasonal influenza vaccine effectiveness across different regions, age groups, and levels of vaccine antigenic similarity with circulating virus strains. The highest vaccine performance was against A(H1N1)pdm09, while the worst was against A(H3N2). Geographic location, age, and vaccine antigenic similarity with circulating virus strains should be considered when designing and evaluating influenza vaccine effectiveness studies.

VACCINE (2021)

Add to Collection

Article Immunology

Relative Effectiveness of Influenza Vaccines Among the United States Elderly, 2018-2019

Hector S. Izurieta et al.

JOURNAL OF INFECTIOUS DISEASES (2020)

Add to Collection

Review Biotechnology & Applied Microbiology

Next-generation influenza vaccines: opportunities and challenges

Chih-Jen Wei et al.

NATURE REVIEWS DRUG DISCOVERY (2020)

Add to Collection

Article Immunology

Relative effectiveness of high dose versus standard dose influenza vaccines in older adult outpatients over four seasons, 2015-16 to 2018-19

G. K. Balasubramani et al.

VACCINE (2020)

Add to Collection

Article Immunology

Influenza Vaccine Effectiveness: Defining the H3N2 Problem

Edward A. Belongia et al.

CLINICAL INFECTIOUS DISEASES (2019)

Add to Collection

Editorial Material Immunology

Comparing Influenza Vaccine Types: The Path Toward Improved Influenza Vaccine Strategies

Brendan Flannery et al.

JOURNAL OF INFECTIOUS DISEASES (2019)

Add to Collection

Article Immunology

Relative Effectiveness of Cell-Cultured and Egg-Based Influenza Vaccines Among Elderly Persons in the United States, 2017-2018

Hector S. Izurieta et al.

JOURNAL OF INFECTIOUS DISEASES (2019)

Add to Collection

Article Immunology

Prevention of Influenza Hospitalization Among Adults in the United States, 2015-2016: Results From the US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN)

Jill M. Ferdinands et al.

JOURNAL OF INFECTIOUS DISEASES (2019)

Add to Collection

Article Immunology

Efficacy and effectiveness of high-dose versus standard-dose influenza vaccination for older adults: a systematic review and meta-analysis

Jason K. H. Lee et al.

EXPERT REVIEW OF VACCINES (2018)

Add to Collection

Article Immunology

Assessing the effectiveness of high-dose influenza vaccine in preventing hospitalization among seniors, and observations on the limitations of effectiveness study design

Steve G. Robison et al.

VACCINE (2018)

Add to Collection

Article Medicine, General & Internal

Efficacy of Recombinant Influenza Vaccine in Adults 50 Years of Age or Older

Lisa M. Dunkle et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Add to Collection

Review Infectious Diseases

Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies

Edward A. Belongia et al.

LANCET INFECTIOUS DISEASES (2016)

Add to Collection

Article Medicine, General & Internal

Influenza Vaccination

John J. Treanor

NEW ENGLAND JOURNAL OF MEDICINE (2016)

Add to Collection

Article Immunology

Prevention of serious events in adults 65 years of age or older: A comparison between high-dose and standard-dose inactivated influenza vaccines

Carlos A. DiazGranados et al.

VACCINE (2015)

Add to Collection

Article Immunology

The case test-negative design for studies of the effectiveness of influenza vaccine

Ivo M. Foppa et al.

VACCINE (2013)

Add to Collection

Review Infectious Diseases

Mortality benefits of influenza vaccination in elderly people: an ongoing controversy

Lone Simonsen et al.

LANCET INFECTIOUS DISEASES (2007)

Add to Collection

© Peeref 2019-2024. All rights reserved.